ASTRAZENECA PLC (AZN)
Clinical trial NCT05820841 updates: 1. completion date: 2028-12-01 → 2029-02-01 2. primary completion date: 2028-04-01 → 2029-02-01
Clinical trial NCT05820841 updates: 1. completion date: 2028-12-01 → 2029-02-01 2. primary completion date: 2028-04-01 → 2029-02-01
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical